Primary mediastinal large B-cell lymphoma

Critical Reviews in Oncology/Hematology

Volumn 68, Issue 3, 2008, Pages 256-263

  Martelli, Maurizio ^a   Ferreri, Andrés J M ^b   Johnson, Peter ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Medical Oncology Unit   (Italy)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Diffuse large B cell lymphoma; Extranodal lymphomas; Mediastinum; Thymic lymphoma

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; PREDNISONE; VINCRISTINE;

AUTOLOGOUS BONE MARROW TRANSPLANTATION; B CELL LYMPHOMA; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; GENE EXPRESSION; HUMAN; IMMUNOPHENOTYPING; INCIDENCE; MORPHOLOGY; PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA; PROGNOSIS; REVIEW; RISK FACTOR;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, B-CELL; MALE; MEDIASTINAL NEOPLASMS; NEOPLASM PROTEINS; PERICARDIAL EFFUSION; PREDNISONE; SURVIVAL RATE; VINCRISTINE;

EID: 54349114239     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2008.07.020     Document Type: Review

References (75)

1. ICD-O. ICD-O. International Classification of Diseases for Oncology. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S, editors. 3rd ed. Geneva: World Health Organization; 2000.
2. Cazals-Hatem D., Lepage E., Brice P., et al. Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study. Am J Surg Pathol 20 (1996) 877-888
3. Falini B., Venturi S., Martelli M., et al. Mediastinal large B-cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third-generation regimens. Br J Haematol 89 (1995) 780-789
4. Bunin N.J., Hvizdala E., Link M., et al. Mediastinal nonlymphoblastic lymphomas in children: a clinicopathologic study. J Clin Oncol 4 (1986) 154-159
5. Jacobson J.O., Aisenberg A.C., Lamarre L., et al. Mediastinal large cell lymphoma. An uncommon subset of adult lymphoma curable with combined modality therapy. Cancer 62 (1988) 1893-1898
6. Perrone T., Frizzera G., and Rosai J. Mediastinal diffuse large-cell lymphoma with sclerosis. A clinicopathologic study of 60 cases. Am J Surg Pathol 10 (1986) 176-191
7. Waldron J.A.J., Dohring E.J., and Farber L.R. Primary large cell lymphomas of the mediastinum: an analysis of 20 cases. Semin Diagn Pathol 2 (1985) 281-295
8. Banks P.M. Incorporation of immunostaining data in anatomic pathology reports. Am J Surg Pathol 16 (1992) 808
9. Lennert K. Malignant lymphomas: other than Hodgkin's disease: histology, cytology, ultrastructure, immunology (1978), Springer-Verlag, Berlin
10. Addis B.J., and Isaacson P.G. Large cell lymphoma of the mediastinum: a B-cell tumour of probable thymic origin. Histopathology 10 (1986) 379-390
11. Hofmann W.J., Momburg F., Moller P., and Otto H.F. Intra- and extrathymic B cells in physiologic and pathologic conditions. Immunohistochemical study on normal thymus and lymphofollicular hyperplasia of the thymus. Virchows Arch A: Pathol Anat Histopathol 412 (1988) 431-442
12. Harris N.L., Jaffe E.S., Stein H., et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84 (1994) 1361-1392
13. Lamarre L., Jacobson J.O., Aisenberg A.C., and Harris N.L. Primary large cell lymphoma of the mediastinum. A histologic and immunophenotypic study of 29 cases. Am J Surg Pathol 13 (1989) 730-739
14. Lavabre-Bertrand T., Donadio D., Fegueux N., et al. A study of 15 cases of primary mediastinal lymphoma of B-cell type. Cancer 69 (1992) 2561-2566
15. Perez-Soler R., McLaughlin P., Velasquez W.S., et al. Clinical features and results of management of superior vena cava syndrome secondary to lymphoma. J Clin Oncol 2 (1984) 260-266
16. Paulli M., Lazzarino M., Gianelli U., et al. Primary mediastinal B-cell lymphoma: update of its clinicopathologic features. Leuk Lymphoma 26 Suppl. 1 (1997) 115-123
17. Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. Tumours of haematopoietic and lymphoid tissue. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). Pathology & Genetics (2001), IRAC Press, Lyon 191-194
18. Pileri S.A., Zinzani P.L., Gaidano G., et al. Pathobiology of primary mediastinal B-cell lymphoma. Leuk Lymphoma 44 Suppl. 3 (2003) S21-S26
19. al-Sharabati M., Chittal S., Duga-Neulat I., et al. Primary anterior mediastinal B-cell lymphoma. A clinicopathologic and immunohistochemical study of 16 cases. Cancer 67 (1991) 2579-2587
20. Pileri S.A., Gaidano G., Zinzani P.L., et al. Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU. 1 in the absence of immunoglobulins. Am J Pathol 162 (2003) 243-253
21. Higgins J.P., and Warnke R.A. CD30 expression is common in mediastinal large B-cell lymphoma. Am J Clin Pathol 112 (1999) 241-247
22. Copie-Bergman C., Plonquet A., Alonso M.A., et al. MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas. Mod Pathol 15 (2002) 1172-1180
23. Klein U., Tu Y., Stolovitzky G.A., et al. Transcriptional analysis of the B cell germinal center reaction. Proc Natl Acad Sci USA 100 (2003) 2639-2644
24. Joos S., Otano-Joos M.I., Ziegler S., et al. Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood 87 (1996) 1571-1578
25. Joos S., Kupper M., Ohl S., et al. Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30 + Hodgkin cells. Cancer Res 60 (2000) 549-552
26. Rossi D., Cerri M., Capello D., et al. Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma. Leukemia 19 (2005) 2363-2366
27. Rosenwald A., Wright G., Leroy K., et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 198 (2003) 851-862
28. Alizadeh A.A., Eisen M.B., Davis R.E., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403 (2000) 503-511
29. Savage K.J., Monti S., Kutok J.L., et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 102 (2003) 3871-3879
30. Marafioti T., Pozzobon M., Hansmann M.L., et al. Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma. Leukemia 19 (2005) 856-861
31. Zamo A., Malpeli G., Scarpa A., et al. Expression of TP73L is a helpful diagnostic marker of primary mediastinal large B-cell lymphomas. Mod Pathol 18 (2005) 1448-1453
32. Levitt L.J., Aisenberg A.C., Harris N.L., Linggood R.M., and Poppema S. Primary non-Hodgkin's lymphoma of the mediastinum. Cancer 50 (1982) 2486-2492
33. Moller P., Lammler B., Eberlein-Gonska M., et al. Primary mediastinal clear cell lymphoma of B-cell type. Virchows Arch A: Pathol Anat Histopathol 409 (1986) 79-92
34. Lazzarino M., Orlandi E., Paulli M., et al. Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients. J Clin Oncol 15 (1997) 1646-1653
35. Zinzani P.L., Bendandi M., Frezza G., et al. Primary mediastinal B-cell lymphoma with sclerosis: clinical and therapeutic evaluation of 22 patients. Leuk Lymphoma 21 (1996) 311-316
36. Lazzarino M., Orlandi E., Astori C., et al. A low serum beta 2-microglobulin level despite bulky tumor is a characteristic feature of primary mediastinal (thymic) large B-cell lymphoma: implications for serologic staging [letter]. Eur J Haematol 57 (1996) 331-333
37. Rodriguez J., Pugh W.C., Romaguera J.E., et al. Primary mediastinal large cell lymphoma is characterized by an inverted pattern of large tumoral mass and low beta 2 microglobulin levels in serum and frequently elevated levels of serum lactate dehydrogenase. Ann Oncol 5 (1994) 847-849
38. Abrahamsen A.F., Lien H.H., Aas M., et al. Magnetic resonance imaging and 67gallium scan in mediastinal malignant lymphoma: a prospective pilot study. Ann Oncol 5 (1994) 433-436
39. Elia S., Cecere C., Giampaglia F., and Ferrante G. Mediastinoscopy vs. anterior mediastinotomy in the diagnosis of mediastinal lymphoma: a randomized trial. Eur J Cardiothorac Surg 6 (1992) 361-365
40. Carbone P.P., Kaplan H.S., Musshoff K., Smithers D.W., and Tubiana M. Report of the committee on Hodgkin's disease staging classification. Cancer Res 31 (1971) 1860-1861
41. Knopp M.V., Bischoff H., Lorenz W.J., and Van Kaick G. PET imaging of lung tumours and mediastinal lymphoma. Nucl Med Biol 21 (1994) 749-757
42. Jerusalem G., Beguin Y., Fassotte M.F., et al. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood 94 (1999) 429-433
43. Spaepen K., Stroobants S., Dupont P., et al. Early restaging positron emission tomography with (18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma. Ann Oncol 13 (2002) 1356-1363
44. Zinzani P.L., Fanti S., Battista G., et al. Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients. Br J Cancer 91 (2004) 850-854
45. Smith C.S., Schoder H., and Yeung H.W. Thymic extension in the superior mediastinum in patients with thymic hyperplasia: potential cause of false-positive findings on 18F-FDG PET/CT. AJR Am J Roentgenol 188 (2007) 1716-1721
46. Zinzani P.L., Tani M., Trisolini R., et al. Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma. Haematologica 92 (2007) 771-777
47. Rohatiner A.Z., Whelan J.S., Ganjoo R.K., et al. Mediastinal large-cell lymphoma with sclerosis (MLCLS). British Journal of Cancer 69 (1994) 601-604
48. Bertini M., Orsucci L., Vitolo U., et al. Stage II large B-cell lymphoma with sclerosis treated with MACOP-B. Ann Oncol 2 (1991) 733-737
49. Lazzarino M., Orlandi E., Paulli M., et al. Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic features. J Clin Oncol 11 (1993) 2306-2313
50. Todeschini G., Ambrosetti A., Meneghini V., et al. Mediastinal large B-cell lymphoma with sclerosis: a clinical study of 21 patients. J Clin Oncol 8 (1990) 804-808
51. Martelli M.P., Martelli M., Pescarmona E., et al. MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis. Ann Oncol 9 (1998) 1027-1029
52. Zinzani P.L., Martelli M., Bertini M., et al. Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients. Haematologica 87 (2002) 1258-1264
53. Todeschini G., Secchi S., Morra E., et al. Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B. Br J Cancer 90 (2004) 372-376
54. Haioun C., Gaulard P., Roudot-Thoraval F., et al. Mediastinal diffuse large-cell lymphoma with sclerosis: a condition with a poor prognosis. Am J Clin Oncol 12 (1989) 425-429
55. Kirn D., Mauch P., Shaffer K., et al. Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients. J Clin Oncol 11 (1993) 1336-1343
56. Romaguera J.E., Rodriguez D., Carias L., et al. Use of the international prognostic index and the tumor score to detect poor-risk patients with primary mediastinal large B-cell lymphoma: a study of 37 previously untreated patients. Leuk Lymphoma 28 (1998) 295-306
57. Abou-Elella A.A., Weisenburger D.D., Vose J.M., et al. Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group. J Clin Oncol 17 (1999) 784-790
58. Lichtenstein A.K., Levine A., Taylor C.R., et al. Primary mediastinal lymphoma in adults. Am J Med 68 (1980) 509-514
59. Zinzani P.L., Martelli M., Magagnoli M., et al. Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)Gallium scan in 50 patients. Blood 94 (1999) 3289-3293
60. Zinzani P.L., Martelli M., Bendandi M., et al. Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy. Haematologica 86 (2001) 187-191
61. Fisher R.I., Gaynor E.R., Dahlberg S., et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma [see comments]. N Engl J Med 328 (1993) 1002-1006
62. Coiffier B., Lepage E., Briere J., et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346 (2002) 235-242
63. Sehn L.H., Donaldson J., Chhanabhai M., et al. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol 23 (2005) 5027-5033
64. Pfreundschuh M., Trumper L., Devinder G., et al. First analysis of the completed Mabthera International (MinT) trial in young patients with low risk diffuse large B-cell lymphoma (DLBCL): addition of rituximab to a CHOP-like regimen significantly improves outcome of all patients with the identification of a very favorable subgroup with IPI = 0 and no bulky disease. Blood 104 (2004) 8a
65. Popat U., Przepiork D., Champlin R., et al. High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome. J Clin Oncol 16 (1998) 63-69
66. Sehn L.H., Antin J.H., Shulman L.N., et al. Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation. Blood 91 (1998) 717-723
67. Haioun C., Lepage E., Gisselbrecht C., et al. Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol-a groupe d'Etude des lymphomes de l'Adulte study. J Clin Oncol 18 (2000) 3025-3030
68. Martelli M., Gherlinzoni F., De Renzo A., et al. Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial. J Clin Oncol 21 (2003) 1255-1262
69. Milpied N., Deconinck E., Gaillard F., et al. Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. N Engl J Med 350 (2004) 1287-1295
70. Strehl J., Mey U., Glasmacher A., et al. High-dose chemotherapy followed by autologous stem cell transplantation as first-line therapy in aggressive non-Hodgkin's lymphoma: a meta-analysis. Haematologica 88 (2003) 1304-1315
71. Aisenberg A.C. Primary large cell lymphoma of the mediastinum. Semin Oncol 26 (1999) 251-258
72. Yahalom J., Petrek J.A., Biddinger P.W., et al. Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients. J Clin Oncol 10 (1992) 1674-1681
73. Yahalom J. Transformation in the use of radiation therapy of Hodgkin lymphoma: new concepts and indications lead to modern field design and are assisted by PET imaging and intensity modulated radiation therapy (IMRT). Eur J Haematol Suppl (2005) 90-97
74. Ratei R., Matylis A., Krahl D., et al. Salvage therapy for relapsed mediastinal B-cell lymphoma with allogeneic HLA-identical related donor bone marrow transplantation, donor lymphocyte infusion and IDEC-C2B8. Leuk Lymphoma 40 (2000) 133-140
75. Nath S.V., and Seymour J.F. Cure of a patient with profoundly chemotherapy-refractory primary mediastinal large B-cell lymphoma: role of rituximab, high-dose therapy, and allogeneic stem cell transplantation. Leuk Lymphoma 46 (2005) 1075-1079